Bioassay Program for Carcinogenic Hazards of Cancer Chemotherapeutic Agents
Authors
Affiliations
Various compounds and combinations thereof, of promise in the treatment of neoplastic diseases, were tested for possible carcinogenicity in Swiss mice and Sprague-Dawley rats. Some of the compounds were fairly active carcinogens, while others showed little or no evidence of carcinogenicity. The carcinogenicity of the drug combinations was generally less than that of the individual components.
Chemical carcinogenesis studies in nonhuman primates.
Takayama S, Thorgeirsson U, Adamson R Proc Jpn Acad Ser B Phys Biol Sci. 2008; 84(6):176-88.
PMID: 18941297 PMC: 3665368. DOI: 10.2183/pjab.84.176.
The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse.
Molyneux G, Gibson F, Chen C, Marway H, McKeag S, Mifsud C Int J Exp Pathol. 2008; 89(2):138-58.
PMID: 18336531 PMC: 2525763. DOI: 10.1111/j.1365-2613.2008.00575.x.
The role of transgenic mouse models in carcinogen identification.
Pritchard J, French J, Davis B, Haseman J Environ Health Perspect. 2003; 111(4):444-54.
PMID: 12676597 PMC: 1241426. DOI: 10.1289/ehp.5778.
Seto Y, Nagawa H, Mori M, Tsuruo T, Muto T Dig Dis Sci. 1999; 44(1):75-8.
PMID: 9952226 DOI: 10.1023/a:1026650000008.
Tumorigenic effect of topical mechlorethamine, BCNU and CCNU in mice.
ZACKHEIM H, SMUCKLER E Experientia. 1980; 36(10):1211-2.
PMID: 7418808 DOI: 10.1007/BF01976135.